New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
07:39 EDTTEVATeva confident U.S. will soon approve new Copaxone, Reuters reports
Teva Pharmaceutical says it's "completely confident" the new version Copaxone, its main multiple sclerosis drug, which features less frequent dosing, will soon be approved in the U.S., reports Reuters. Teva's branded MS drug accounts for about 20% of sales and 50% of Teva profits.Reference Link
News For TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
06:28 EDTTEVAAllergan price target raised to $210 from $190 at Citigroup
Subscribe for More Information
October 14, 2014
11:23 EDTTEVABIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
11:19 EDTTEVATeva upgraded to Buy from Hold at Standpoint Research

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use